Blog Archives

Novina Lab in the News!

8/21/2018

Kevin O'Leary, famous for his role as a judge on "Shark Tank," was the keynote speaker at the Harvard Biotech Club’s Fall 2018 Kick-Off Event. Dr. Carl Novina and Dr. Fred Mermelstein joined Kevin O'Leary in introducing the club's fall education initiatives and inspiring young scientists and entrepreneurs to connect academia and business. Read the Boston Globe article here.

0 Comments

Funding Alert!

8/2/2018

0 Comments

Dr. David Reardon (Clinical Director, Center for Neuro-Oncology) in collaboration with the Novina Lab received the Alliance for Cancer Gene Therapy (ACGT) 2018 Innovator Grant! “This work represents the next generation of gene therapies,” noted Margaret Cianci, executive director of ACGT. “Two of the three grants fund crucial research leading to the development of cancer vaccines, among the most promising forms of gene therapy. These vaccines are not like traditional vaccines – no live pathogens are used to establish a barrier to the disease. Instead, cancer vaccines contain inactive viruses or a patient’s modified cancer cells to penetrate just the cancer and then serve as a beacon for the immune system to attack. Advances in medical technology have also made it possible to customize vaccines to DNA and to specific forms of cancer. We are very excited about this research and hope to see major steps forward in the treatment of solid cancers with these different methodologies.” Read more about the grant here.

0 Comments

Novina Lab in the News!

Funding Alert!

Novina Lab News

Archives

Categories